全球青光眼手术设备市场（2024年）：2023年至2029年分析

本报告调查了全球青光眼手术器械市场，重点介绍了微支架、结膜下分流器、管手术器械和管分流器的产品类别，提供未来五年的市场表现和主要趋势预测，未来重要趋势 ，以及进入市场的22 家公司的公司简介。也调查青光眼手术中使用的雷射。

目录

• 有关青光眼、青光眼人口和青光眼诊断的背景信息
• 青光眼设备目前的销售预测，包括平均价格和总收入
• 潜在设备买家概况，包括眼科医师、眼科专家、验光师及一般医生
• 有关製造商的信息
• 当前偿付率

What's New:

The new "2024 Glaucoma Surgical Device Market Report" provides an in-depth look at a record 18 early-stage glaucoma device and laser companies. Iantrek, led by one of ophthalmology's most prolific innovators, is preparing to launch several revolutionary glaucoma treatments, including the AlloFlo, the first biotissue stent.

Several promising new subconjunctival products are also examined. These include Avisi Technologies' ultrathin filtration plate implant, Myra Vision's adjustable post-op shunt, and Ciliatech's uveoscleral filtration acrylic plate.

The report also highlights emerging laser technologies that have the potential to dramatically expand the use of lasers in glaucoma, such as the Belkin DSLT laser, ViaLase femtosecond laser, Elios ELT laser, and IOPtimate CO2 laser.

In addition, the report tracks advancements in sustained drug delivery devices, providing insights into ongoing progress in this field.

The "2024 Glaucoma Surgical Device Market Report" offers a comprehensive analysis of the current global market for glaucoma devices, as well as a discussion of important trends, an examination of upcoming products that will impact the market, and a review of other key factors shaping future success.

The report analyzes the prevalence of glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes.

Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-two market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

The report focuses on the product categories of microstents, formerly referred to as minimally invasive glaucoma surgery (MIGS) devices; subconjunctival shunts; canal surgery devices; and tube shunts. It also examines lasers used in glaucoma procedures. Each segment provides an analysis of market competitors and five-year market forecasts for units and dollars.

Also included in the report:

• Background information about glaucoma, glaucoma populations, and glaucoma diagnosis.
• Estimates of current sales and sales forecasts for glaucoma devices, including average prices and total revenue.
• Profiles of prospective device buyers, including ophthalmologists, ophthalmic specialists, optometrists, and general medical doctors.
• Information about manufacturers.
• Current reimbursement rates.